ABSTRACT 132-Microglobulin (f82m) is a major constituent of amyloid fibrils in patients with dialysis-related amyloidosis (DRA). Recently, we found that the pigmented and fluorescent adducts formed nonenzymatically between sugar and protein, known as advanced glycation end products (AGEs), were present in f32m-containing amyloid fibrils, suggesting the possible involvement of AGE-modified f32m in bone and joint destruction in DRA. As an extension of our search for the native structure ofAGEs in 132m of patients with DRA, the present study focused on pentosidine, a fluorescent cross-linked glycoxidation product. Determination by both HPLC assay and competitive ELISA demonstrated a significant amount of pentosidine in amyloid-fibril J2m from longterm hemodialysis patients with DRA, and the acidic isoform Of f82m in the serum and urine of hemodialysis patients. A further immunohistochemical study revealed the positive immunostaining for pentosidine and immunoreactive AGEs and f82m in macrophage-infiltrated amyloid deposits of long-term hemodialysis patients with DRA. These findings implicate a potential link of glycoxidation products in long-lived 82m-containing amyloid fibrils to the pathogenesis of DRA.
term hemodialysis patients with DRA, and the acidic isoform Of f82m in the serum and urine of hemodialysis patients. A further immunohistochemical study revealed the positive immunostaining for pentosidine and immunoreactive AGEs and f82m in macrophage-infiltrated amyloid deposits of long-term hemodialysis patients with DRA. These findings implicate a potential link of glycoxidation products in long-lived 82m-containing amyloid fibrils to the pathogenesis of DRA. f32-Microglobulin (j32m) is a major constituent of amyloid fibrils in dialysis-related amyloidosis (DRA), a serious complication of long-term hemodialysis patients (1) . Amyloid deposits are mainly located in joint structures, especially in periarticular bones, leading to bone and joint destruction (1) .
In the Maillard reaction (2, 3) , sugar aldehydes react with protein amino groups to form the early products such as Schiff base and Amadori products. Through a series of chemical rearrangement, dehydration, and fragmentation reactions, some Amadori products are further converted to the advanced glycation end products (AGEs) with a fluorescence and brown color. AGEs have been implicated in tissue damage associated with diabetic complication and aging (2, 3) . We recently found that AGEs are present in f32m-containing amyloid fibrils isolated from patients with DRA (4) . AGEs are also demonstrated to occur in the acidic isoform of f32m, a small fraction of the serum and urine 2m in long-term hemodialysis patients (4) . Our subsequent study has revealed that acidic 32m purified from the patients' urine induces chemotaxis of monocytes and secretion of potent bone-resorbing cytokines from macrophages such as tumor necrosis factor a (TNF-a), interleukin 1B, and interleukin 6 (5, 6) . These results likely suggest a potential role of AGEs in bone and joint destruction of DRA.
Pentosidine has recently been postulated to be one of AGE structures (7) . It has been identified in vivo in skin collagen and plasma proteins of diabetic patients (8) (9) (10) (11) and hemodialysis patients (10) (11) (12) , in aged lens (11, 13) , and in senile plaques of
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brain tissue from patients with Alzheimer disease (14) and is thus being used as fluorescent glycoxidation marker for AGEs (15) . The present study was undertaken to quantitate pentosidine in amyloid-fibril f32m and acidic f32m purified from long-term hemodialysis patients by using an HPLC assay and a competitive ELISA with the specific anti-pentosidine antibody. An immunohistochemical approach to detect pentosidine was also made.
MATERIALS AND METHODS
Isolation of Amyloid Fibril Proteins. Tenosynovial tissues from the head of the humerus, the head of the femur or patella, or intervertebral discs were obtained postmortem from three long-term hemodialysis patients with DRA (three men from 59 to 78 years old who underwent hemodialysis for 13-20 years). Amyloid fibril proteins were purified from these tissues as described (4) . For immunoblot analysis, amyloid fibril proteins were solubilized in water containing 2% (wt/vol) SDS and 8 M urea.
Purification of Normal f82m and Acidic f32m. Normal and acidic isoforms of human f32m were purified from urine of five nondiabetic hemodialysis patients who were free of urinary infection (three men and two women from 44 to 64 years old who underwent hemodialysis for 6-11 years) as described (4 (17) , or anti-,32m rabbit IgG overnight at room temperature.
The sections for pentosidine were incubated with goat antirabbit IgG conjugated with 1-nm immunogold (Biocell Laboratories) or goat anti-rabbit IgG conjugated with alkaline phosphatase (Dakopatts). For detection of AGEs, sections were incubated with goat anti-mouse IgG conjugated with alkaline phosphatase (Dakopatts). For detection of f2m, sections were incubated with biotinylated goat anti-rabbit IgG (Dakopatts), followed by incubation with peroxidase-conjugated streptavidin (Dakopatts). The sections were processed by using a kit (Silver Enhancing Kit-Light Microscopy, Biocell Laboratories) for immunogold staining, by using a 5-bromo-4-chloro-3-indolyl phosphate and nitro blue tetrazolium solution for alkaline phosphatase staining, or by using a 3,3'-diaminobenzidine solution containing 0.003% H202 for peroxidase staining.
RESULTS
Presence of Pentosidine in Acidic 32m and Amyloid-Fibril f32m1 Pentosidine ( Fig. 1 ) was first quantitated in hydrolyzed samples by HPLC. Fig. 2A Proc. Natl. Acad. Sci. USA 93 (1996) detective level in glycated 132m after a 30-day incubation in the presence of NaBH3CN, which inhibits pentosidine formation by reducing Schiff base and preventing Amadori rearrangement.
Pentosidine in hydrolyzed samples was also quantitated by a competitive ELISA. The detection limit calculated as the least amount of pentosidine significantly different from zero at 95% confidence limits was 0.1 pmol and 50% inhibition was obtained by 2.3 pmol of free pentosidine (Fig. 3A) . The linear portion of the curve (0.1-100 pmol) was used as a working range. The immunoreactivity was inhibited by hydrolyzed pentosidine-p32m or pentosidine-BSA, and the inhibition curves were parallel to that of pentosidine, whereas normal ,B2m or BSA did not inhibit the immunoreaction (Fig. 3B) .
Pentosidine levels were below the detection level in normal f2m (<0.01 pmol/,ug) but were significant in acidic 132m (0.23 + 0.12 pmol/,ug) and amyloid fibril proteins (0.17 + 0.04 pmol/,g), supporting the presence of pentosidine in acidic j32m and amyloid fibril f32m (Fig. 3C) . Pentosidine levels in glycated f32m after 14-day, 30-day, and 70-day incubations were 0.03 pmol/,ug, 0.10 pmol/,ug, and 0.22 pmol/j.g, respectively, but were undetectable in glycated g32m after a 30-day incubation in the presence of NaBH3CN. The pentosidine levels obtained by HPLC assay significantly correlated with those obtained by competitive ELISA (logy = 0.994 logx + 0.303, where x and y are pentosidine levels estimated by HPLC assay andcompetitiveELISA,respectively;r = 0.986;P < 0.0001) (Fig. 4) .
The immunoblot analysis showed that urine acidic f32m ( (Fig.  5C ), whereas no immunoreaction was observed with either normal f32m (lane 1) or glycated f32m after a 14-day incubation (data not shown). Two acidic f32m samples purified from sera of two hemodialysis patients reacted with the antibody, but the corresponding normal f32m purified from the sera of these patients did not (data not shown). This antibody also reacted with glycated BSA (lane 7) and pentosidine-BSA (lane 8 rabbit IgG (lane 9), reflecting a high specificity of the immunoreaction of the anti-pentosidine antibody. Fig. 5B shows the result of immunoblot analysis of the same specimens by the anti-AGE antibody used in our previous study (4 positive for Congo red (Fig. 6A ) with green birefringence under polarized light. The positive immunostaining for f32m was observed in these deposits (Fig. 6 B and E) . The deposits were surrounded with a number of mononuclear cells that were stained positive for CD68 (data not shown), indicating that the infiltrating cells were tissue macrophages as shown (18) . Of note, both pentosidine ( Fig. 6 C and F) and AGEs (Fig. 6D) were stained in these amyloid deposits and slightly in adjacent matrix tissues. The weak staining for pentosidine was also detected in matrix tissues of normal subjects who were relatively elderly to match with the hemodialysis patients studied (data not shown). Staining patterns of pentosidine and AGEs in these deposits were not always identical with that of 132m. In contrast to the homogeneous staining pattern of 132m, pentosidine and AGEs in the amyloid deposits had a patchy staining pattern. Within the same amyloid tissue, the staining intensity for pentosidine and AGEs was strong in some deposits whereas it was rather weak in the other deposits. Preadsorption of anti-pentosidine antibody or the anti-AGE antibody by free pentosidine or glycated BSA, respectively, abolished the immunostaining while preadsorption with BSA did not affect the immunostaining (data not shown). Nonimmune rabbit or mouse IgG gave no immunostaining pattern (data not shown).
DISCUSSION
The question of particular interest is the mechanism of pentosidine and AGEs formation in amyloid deposits. Since the formation of pentosidine and AGEs is accompanied by intraand/or intermolecular cross-linking of proteins (7), one explanation may be that modification of plasma 132m by pentosidine and AGEs gives rise to acidic 632m, which is transferred to an extravascular space, where acidic ,12m is taken up through the AGE receptor (19, 20) by tissue macrophages. Alternatively, since the AGE modification occurs preferably in longlived proteins in vivo and amyloid fibril proteins are known to have a long lifetime due to an extreme insolubility and resistance to proteases, the modification may take place directly in situ in long-lived amyloid-fibril f32m. Presumably, both mechanisms could operate simultaneously. In our preliminary immunohistochemical study, both pentosidine and AGEs are present in old connective tissues, especially in intervertebral discs, a finding consistent with the previous one that old human dura mater collagen contained a significant amount of pentosidine (7) . The presence of pentosidine in the connective tissue may indicate the in situ accumulation of AGE-modified long-lived matrix proteins such as collagen fibers.
One intriguing issue, remaining unresolved, is the involvement of pentosidine in amyloid formation (amyloidogenesis) of f32m. A high concentration of intact f32m is known to lead to formation of amyloid fibrils (21) . This likely indicates that normal f32m by itself possesses a potential capacity to form amyloid fibrils, suggesting that the secondary structure (,3-pleated sheet) of ,32m may be an important factor for amyloid formation. However, it takes a high protein concentration and a prolonged incubation period as well for normal 132m alone to form fibrillar structures. Thus, the characteristic property of pentosidine as a protein cross-linker may contribute to enhance amyloid formation. A recent study has demonstrated that AGE-modified 3-amyloid peptide accelerated aggregation of soluble f3-amyloid peptide compared to nonmodified form, suggesting the possible involvement of AGEs in the amyloidogenesis of Alzheimer disease (22) . Pentosidine was also reported to occur in senile amyloid plaques of brain tissue from these patients (14) . These results implicate the possibility that the modification of f32m with pentosidine might be an initial event during the amyloidogenesis of 132m. However, a more likely explanation is that pentosidine is not directly involved in the amyloidogenesis because it is present in substoichiometric concentrations. Pentosidine, however, represents accumulation of many post-translational modifications since it cannot form independently from other advanced modifications of the Maillard reaction (7, 16) .
Pentosidine formation is thought to be related to oxidative stress, since oxygen is required for its synthesis (15, 16, 23) and increased glycation is known to promote the formation of free radical formation and enhance oxidative damage to proteins and lipids (24) . These findings indicate an oxidative mechanism in the formation of AGEs, thereby termed recently as glycoxidation (15) . Baynes and his associates (9, 25) have suggested the possible involvement of oxidative processes during pentosidine formation in the development of diabetic complications. Therefore, not only glycation but also oxidative stress associated with pentosidine formation might function in the development of bone and joint destruction of DRA. As one of the AGE structures expressed in vivo, the present study has focused on pentosidine. However, there could remain other epitopes that cross-react with the anti-AGE antibody (17) but not with the anti-pentosidine antibody. The anti-AGE antibody used in the present study reacts with an AGE structure(s) other than 2-(2-furoyl)-4(5)-(2-furanyl)-lHimidazole (FFI) (26) and pyrraline (27) . Makita et al. (28) have also shown that pentosidine, FFI, and pyrraline are not recognized by their anti-AGE antibody. The exact epitope of these anti-AGE antibodies has not been clarified. However, a recent study demonstrated that carboxymethyllysine is the major AGE epitope, recognized in human tissue proteins by polyclonal anti-AGE antibody (29) . Further characterization of the epitope structure(s) of these antibodies will facilitate our understanding not only of the reaction mechanism of the advanced stage of the Maillard reaction but also of the pathophysiological role of AGEs.
A previous report showed that amyloid deposits of longterm hemodialysis patients with severe DRA were surrounded by a number of macrophages that were immunochemically positive for interleukin 1f3 and TNF-a (18) . Based on our previous findings that AGE-modified f32m induces chemotaxis of monocytes and secretion of potent bone-resorbing cytokines from macrophages (5, 6) , the presence of a significant amount of pentosidine and AGEs in long-lived amyloid deposits with a marked infiltration of macrophages supports our hypothesis that monocytes/macrophages accumulate in amyloid deposits and initiate the inflammatory response leading to bone and joint destruction in DRA the argument for the role of AGEs in DRA? Three factors should be considered in this regard. (i) The deposition of amyloid fibrils increases with the duration of hemodialysis treatment (1) and, in patients undergoing long-term hemodialysis (e.g., >10 years), some degree of amyloid deposits is always present (18) . Tissue destruction of DRA occurs in >65% of the patients hemodialyzed for >10 years and in most if not all patients hemodialyzed for >15 years (1). Thus, eventually all patients will go on to develop tissue destruction.
(ii) The occurrence of DRA increases with the age of the patient at onset of hemodialysis; i.e., elderly patients are more susceptible to DRA than younger patients (30) . (iii) The rate of progression of tissue destruction in response to AGEs may relate to individual differences in macrophage response to AGEs. It is known that the macrophage receptor for AGEs can be up-regulated by TNF-a (31) and that individuals vary greatly in their levels of TNF-a expression (32) . Thus, AGEmediated tissue destruction would be the combined result of excessive accumulation of AGEs and amyloid deposits linked to a heightened macrophage response to these deposits.
